Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$12.92−0.48 (-3.58%)
Close on Nov 16, 2026Market cap $172.91MP/E –Yield –
Anika Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Anika Therapeutics's ebitda for the twelve months ending Jun 30, 2026 was $500.00K. For fiscal 2025 it was -$5.68M, down 418.5% from the year before. The highest annual figure on record is $66.15M in fiscal 2014.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.68M | -418.5% |
| FY2024 | Dec 31, 2024 | $1.78M | -75.5% |
| FY2023 | Dec 31, 2023 | $7.28M | -29.8% |
| FY2022 | Dec 31, 2022 | $10.37M | +14.1% |
| FY2021 | Dec 31, 2021 | $9.10M | – |
| FY2020 | Dec 31, 2020 | -$22.24M | -156.7% |
| FY2019 | Dec 31, 2019 | $39.21M | +41.7% |
| FY2018 | Dec 31, 2018 | $27.66M | -44.7% |
| FY2017 | Dec 31, 2017 | $50.02M | -8.0% |
| FY2016 | Dec 31, 2016 | $54.34M | +4.7% |
| FY2015 | Dec 31, 2015 | $51.91M | -21.5% |
| FY2014 | Dec 31, 2014 | $66.15M | +77.0% |
| FY2013 | Dec 31, 2013 | $37.38M | +54.2% |
| FY2012 | Dec 31, 2012 | $24.24M | +34.9% |
| FY2011 | Dec 31, 2011 | $17.97M | +65.5% |
| FY2010 | Dec 31, 2010 | $10.86M | +57.8% |
| FY2009 | Dec 31, 2009 | $6.88M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.46M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.08M | – |
| Q4 FY2025 | Dec 31, 2025 | $1.96M | +129.7% |
| Q3 FY2025 | Sep 30, 2025 | -$1.84M | -203.5% |
| Q2 FY2025 | Jun 30, 2025 | -$2.90M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.90M | – |
| Q4 FY2024 | Dec 31, 2024 | $855.00K | -96.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.78M | – |
| Q2 FY2024 | Jun 30, 2024 | -$80.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$771.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $26.33M | +45.3% |
| Q3 FY2023 | Sep 30, 2023 | -$6.08M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.03M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.95M | – |
| Q4 FY2022 | Dec 31, 2022 | $18.12M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.25M | -245.7% |
| Q2 FY2022 | Jun 30, 2022 | -$1.62M | -115.1% |
| Q1 FY2022 | Mar 31, 2022 | -$1.88M | -167.2% |
| Q4 FY2021 | Dec 31, 2021 | -$7.35M | – |
| Q3 FY2021 | Sep 30, 2021 | $2.92M | – |
| Q2 FY2021 | Jun 30, 2021 | $10.72M | – |
| Q1 FY2021 | Mar 31, 2021 | $2.80M | -71.6% |
| Q4 FY2020 | Dec 31, 2020 | -$16.42M | -409.7% |
| Q3 FY2020 | Sep 30, 2020 | -$9.84M | -172.5% |
| Q2 FY2020 | Jun 30, 2020 | -$5.84M | -143.6% |
| Q1 FY2020 | Mar 31, 2020 | $9.86M | +41.6% |
| Q4 FY2019 | Dec 31, 2019 | $5.30M | -52.8% |
| Q3 FY2019 | Sep 30, 2019 | $13.57M | +34.5% |
| Q2 FY2019 | Jun 30, 2019 | $13.38M | +5.4% |
| Q1 FY2019 | Mar 31, 2019 | $6.96M | – |
| Q4 FY2018 | Dec 31, 2018 | $11.24M | +4.1% |
| Q3 FY2018 | Sep 30, 2018 | $10.09M | -12.1% |
| Q2 FY2018 | Jun 30, 2018 | $12.69M | -32.2% |
| Q1 FY2018 | Mar 31, 2018 | -$6.36M | -170.5% |
| Q4 FY2017 | Dec 31, 2017 | $10.79M | -21.2% |
| Q3 FY2017 | Sep 30, 2017 | $11.47M | -21.2% |
| Q2 FY2017 | Jun 30, 2017 | $18.73M | – |
| Q1 FY2017 | Mar 31, 2017 | $9.02M | – |
| Q4 FY2016 | Dec 31, 2016 | $13.70M | – |
| Q3 FY2016 | Sep 30, 2016 | $14.57M | – |
See a number that looks wrong?